John Barstis

Cost savings associated with the use of fine‐needle aspiration biopsy (FNAB) for the diagnosis of palpable masses in a community hospital‐based FNAB clinic

B. Florentine, Barry Staymates, M. Rabadi, 2006, Cancer.

The reliability of fine‐needle aspiration biopsy as the initial diagnostic procedure for palpable masses

B. Florentine, Barry Staymates, M. Rabadi, 2006, Cancer.

Phase II trial of infusional fluorouracil, leucovorin, mitomycin, and dipyridamole in locally advanced unresectable pancreatic adenocarcinoma: SWOG S9700.

P. Philip, A. Jazieh, J. Macdonald, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Multicenter, randomized trial for stage IIIB or IV non-small-cell lung cancer using weekly paclitaxel and carboplatin followed by maintenance weekly paclitaxel or observation.

M. Perry, C. Belani, G. Mills, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Final Results of a Phase II Trial Evaluating Trastuzumab and Bevacizumab as First Line Treatment of HER2-Amplified Advanced Breast Cancer.

D. Elashoff, R. Hermann, C. Vogel, 2009 .

Breast‐Conservation Treatment Outcomes: A Community Hospital’s Experience

Boris OGUIBENINE, R. Zimmerman, B. Florentine, 2009, The breast journal.

O-093 Meta-analysis of weekly paclitaxel as maintenance therapy foradvanced non-small cell lung cancer (NSCLC) patients following intitial chemotherapy

S. Ramalingam, M. Perry, C. Belani, 2005 .

Phase II multicenter randomized trial of induction weekly paclitaxel (P) administered in combination with carboplatin (C) followed by weekly maintenance P vs. observation for patients (pts.) with advanced & metastatic non-small cell lung cancer (NSCLC)

M. Perry, C. Belani, G. Mills, 2000 .

Treatment of Elderly Non–small Cell Lung Cancer Patients with Three Different Schedules of Weekly Paclitaxel in Combination with Carboplatin: Subanalysis of a Randomized Trial

S. Ramalingam, M. Perry, C. Belani, 2006, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Excellent tolerance of rituximab when given after mitoxantrone/cyclophosphamide: an effective and safe combination for indolent non-Hodgkin's lymphoma.

W. Grody, L. Bosserman, C. Emmanouilides, 2000, Clinical lymphoma.